Farxiga (dapagliflozin) is a prescription drug that’s used for type 2 diabetes, heart failure, kidney disease, and other conditions. Farxiga comes as an oral tablet. Farxiga (dapagliflozin) is used in ...
BARCELONA—Earlier this month, AstraZeneca turned heads with outcomes data showing its Farxiga (dapagliflozin) could improve heart failure outcomes for people both with and without diabetes. And now, ...
Both Farxiga (dapagliflozin) and Jardiance (empagliflozin) help manage blood sugar levels in adults and some children with type 2 diabetes. They also reduce risks associated with chronic kidney ...
Farxiga (dapagliflozin) is an oral tablet medication that comes in strengths of 5 milligrams (mg) and 10 mg. The specific Farxiga dosage prescribed depends on the medical condition being treated. The ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...
AstraZeneca has watched superstar SGLT2 diabetes med Farxiga nail trial after trial in highly coveted kidney and heart failure indications, with the FDA expediting reviews to back them up. The one ...
The FDA’s Office of Prescription Drug Promotion issued an Untitled Letter, backdated to September 23, to Tracey M. Henderson, MS, MBA – AstraZeneca’s promotional regulatory affairs review director, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results